DAVITA INC (DVA)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for DVA
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| DVA | President, Chief Executive Officer and Chairman of the Board; Member | 61 | ["Chairman of the Board of Labcorp since May 2020","Director of Labcorp since April 2013","President and CEO of Labcorp since November 2019","Former special advisor to the CEO of Merck from January 2019 to July 2019","Former President, Global Human Health and Executive Vice President of Merck from 2010 to 2018","NACD CERT Certificate in Cyber-Risk Oversight earned in 2022","Extensive knowledge of healthcare industry","audit committee financial expert"] | ["Audit Committee","Compensation Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| LH | President & CEO, Laboratory Corporation of America Holdings; Chairman, President and Chief Executive Officer | 58 | ["Global and U.S.-focused leadership roles, while at Merck, spanning sales, marketing, and managed markets, as well as business and product development","Deep knowledge of the pharmaceutical and healthcare industries and extensive experience collaborating with many of the industries’ key stakeholders to achieve patient-focused outcomes","CERT Certificate in Cybersecurity Oversight"] | ["Vice Chair of the Board of Directors for the American Clinical Laboratory Association","Board Member of Water.org","Corporate Advisory Council for the National Alliance for Hispanic Health"] | 2023 |
Biography sourced from the proxy statement filing.
Adam H. Schechter , 60, has served as Chairman of the Board of Directors of Labcorp Holdings Inc. (formerly known as Laboratory Corporation of America Holdings) ("Labcorp"), a leading global life sciences company, since May 2020, as a director of Labcorp since April 2013, and President and CEO since November 2019. Mr. Schechter previously served as special advisor to the CEO of Merck & Co., Inc. ( Merck ), a multinational pharmaceutical company, from January 2019 to July 2019. From 2010 to 2018, Mr. Schechter was an Executive Vice President of Merck, where he was a member of Merck s executive committee, pharmaceutical and vaccines operating committee, and President of Merck s Global Human Health Division, which included Merck s worldwide pharmaceutical and vaccine businesses. Prior to becoming President, Global Human Health, Mr. Schechter served as President, Global Pharmaceutical Business of Merck from 2007 to 2010. In 2022, Mr. Schechter earned the NACD CERT Certificate in Cyber-Risk Oversight. Mr. Schechter brings to the Board extensive knowledge of the healthcare industry, operations and regulatory environment, and significant executive leadership and management experience.